Table 2.
Estradiol uniquely downregulates signaling pathways in activated SLE T cells but not in normal T cells. Gene lists that were generated from microarray data were analyzed for pathways uniquely downregulated in all SLE T cells and not in the control T cells. List shown is of pathways which met the criteria for significance (p ≤ 0.05) in SLE T cells.
| Pathway | SLE T cells p-value | Control T cells p-value |
|---|---|---|
| PPARα/RXRγ Activation | 0.0006 | NS |
| G-Protein Coupled Receptor Signaling | 0.0017 | NS |
| Hepatic Fibrosis/Hepatic Stellate Cell Activation | 0.0019 | NS |
| cAMP-mediated Signaling | 0.0024 | NS |
| Nitrogen Metabolism | 0.0058 | NS |
| Propanoate Metabolism | 0.0102 | NS |
| Circadian Rhythm Signaling | 0.0120 | NS |
| Axonal Guidance Signaling | 0.0174 | NS |
| Keratan Sulfate Biosynthesis | 0.0234 | NS |
| Calcium Signaling | 0.0275 | NS |
| Fatty Acid Metabolism | 0.0282 | NS |
| Valine, Leucine and Isoleucine Degradation | 0.0309 | NS |
| Cardiac β2-adrenergic Signaling | 0.0324 | NS |
| β-alanine Metabolism | 0.0417 | NS |
| Phospholipid Degradation | 0.0417 | NS |
| Synaptic Long Term Potentiation | 0.0437 | NS |
| LPS/IL-1 Mediated Inhibition of RXR Function | 0.0437 | NS |
| TGF-β Signaling | 0.0447 | NS |
| IL-2 Signaling | 0.0457 | NS |
| Amyloid Processing | 0.0457 | NS |